The director of the institute pointed out that when this highly specialized center was established, it was the seed of genetic medicine in the country.
Jorge Melendez Zagla, Director General of the National Institute of Genomic Medicine (Enigmagen), I stood up who Your organization has conducted more than 600,000 tests for COVID-19. It has served as a model for other entities in adapting their capabilities to emergencies such as SARS-CoV-2.
The Director General stressed that the Institute has made the new knowledge in genetics obtained in its laboratories and classrooms available to the community, and applied it in medical prevention and treatment.
Read: COVID-19: Everything you need to know about symptoms and new wave of infections
Likewise, Jorge Meléndez Zagla emphasized that when this highly specialized center was created, it was the seed of genomic medicine in the country, which is now being implemented in the clinic.
“It is time to bring together the valuable knowledge generated by various national and international scientific groups to prevent and solve major national health problems.”He confirmed.
He explained that access to genomic technology at the tertiary level of care reduces costs and increasing the number of genomic tests increases the prevention or timely detection of diseases.
To achieve this goal, Inmegen maintains close and continuous cooperation with the entire health sector.
Read also: Mexico records more than 20,000 dengue cases and 49 deaths as of July 8
And YC.
“Creator. Devoted pop culture specialist. Certified web fanatic. Unapologetic coffee lover.”